NCT04794127 2026-02-18
TRABEPIO
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
Clinical Trials
31 trialsNCT05919147 2025-07-04
TRACE-1
Pennington Biomedical Research Center
Phase 2 Active not recruiting
NCT05013255 2025-04-08
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
West Virginia University
Phase 2 Recruiting
NCT02852486 2025-03-30
EDI-PIO
University of Campinas, Brazil
Phase 2 Completed
NCT02942758 2024-05-08
AML-ViVA
University Hospital Regensburg
Phase 2 Terminated
NCT05098327 2023-08-15
Pioglitazone and Insulin Resistance in ADT
State University of New York at Buffalo
Phase 3 Withdrawn
NCT04995978 2023-06-23
Insulin Resistance and Androgen Deprivation Therapy
St. Louis University
Phase 2 Withdrawn
NCT04658849 2023-05-15
Insulin Resistance Following ADT for Prostate CA
St. Louis University
Phase EARLY_PHASE1 Withdrawn
NCT00203996 2023-03-21
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
University of Chicago
Phase 4 Terminated
NCT05753657 2023-03-03
A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
Rambam Health Care Campus
Phase EARLY_PHASE1 Recruiting
NCT05519813 2022-08-29
Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.
Shengjing Hospital
Phase 4 Unknown
NCT01935466 2022-01-25
PROBE-PIO
Post Graduate Institute of Medical Education and Research, Chandigarh
Completed
NCT04867252 2021-09-13
Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase 2 Completed
NCT04883125 2021-05-12
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
Mansoura University
Phase 2 Completed
NCT01838317 2021-03-01
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT02767063 2020-08-07
ACTIW
Versailles Hospital
Phase 1/2 Unknown
NCT02347813 2020-06-23
Preventing Squamous Cell Skin Cancer
University of Rochester
Phase 2 Completed
NCT03117517 2020-03-02
Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase EARLY_PHASE1 Completed
NCT02689843 2019-11-12
AntiPCO
Shiraz University of Medical Sciences
Phase EARLY_PHASE1 Completed
NCT00694759 2019-09-09
Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
Oregon Health and Science University
Phase NA Completed
NCT00867126 2018-11-26
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT01151670 2018-08-01
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Wake Forest University Health Sciences
Phase 1 Completed
NCT02889003 2018-03-22
PIO2STOP
Versailles Hospital
Phase 2 Unknown
NCT02852083 2018-01-18
ModuLung
University Hospital Regensburg
Phase 2 Unknown
NCT00868140 2016-06-10
PCOS
Virginia Commonwealth University
Phase NA Terminated
NCT02133625 2016-05-13
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Dana-Farber Cancer Institute
Phase 1 Completed
NCT02475499 2016-03-14
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES
Completed
NCT02687425 2016-02-22
SESPI
Tongji Hospital
Phase 2 Unknown
NCT01223196 2016-01-11
PIO-TACE
The University of Texas Health Science Center at San Antonio
Phase 4 Completed
NCT01010243 2012-05-30
MM03
University of Regensburg
Phase 1/2 Unknown
NCT00145340 2008-09-26
Pioglitazone Treatment in Polycystic Ovary Syndrome
Odense University Hospital
Phase 4 Completed